血管紧张素Ⅱ受体1(AGTR1)重组蛋白
Recombinant Angiotensin II Receptor 1 (AGTR1)
AT1R; AG2S; AG2-S; AGTR1A; AGTR1B; AT1; AT1B; AT2R1; AT2-R1; AT2R1A; AT2R1B; HAT1R; AT1 Receptor; Angiotensin Receptor 1B
- 编号RPB658Hu02
- 物种Homo sapiens (Human，人) 相同的名称，不同的物种。
- 来源原核表达
- 宿主E.coli
- 内毒素水平<1.0EU/µg(LAL法测定)
- 亚细胞定位细胞膜
- 预测分子量44.0kDa
- 实际分子量43kDa(差异分析请参阅说明书)
- 片段与标签Met1~Ile124 with N-terminal His and GST Tag
- 缓冲液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性状冻干粉
- 纯度> 90%
- 等电点8.3
-
应用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，请参见活性蛋白。 - 下载 英文说明书 中文说明书
- 规格 10µg50µg 200µg 1mg 5mg
- 价格 ¥ 1207 ¥ 3018 ¥ 6036 ¥ 18108 ¥ 45270
- 欲了解实际交易价格和更多情况，请与当地经销商联系!
-
产品包装(模拟)
-
产品包装(模拟)
-
Figure . Gene Sequencing (extract)
-
Figure. SDS-PAGE
-
通过ISO 9001、ISO 13485质量体系认证
序列
用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
储存
避免反复冻融。2-8°C不超过一个月，-80°C不超过12个月。
稳定性
热稳定性以损失率显示。损失率是由加速降解试验决定，具体方法如下：在37°C孵育48小时，没有显著的降解或者沉淀产生。保质期内，在适当的条件下存储，损失率低于5%。
增值服务
相关产品
| 编号 | 适用物种：Homo sapiens (Human，人) | 应用(仅供研究使用，不用于临床诊断！) |
| RPB658Hu02 | 血管紧张素Ⅱ受体1(AGTR1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB658Hu03 | 血管紧张素Ⅱ受体1(AGTR1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPB658Hu01 | 血管紧张素Ⅱ受体1(AGTR1)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB658Hu01 | 血管紧张素Ⅱ受体1(AGTR1)多克隆抗体 | WB; IHC; ICC; IP. |
| MAB658Hu22 | 血管紧张素Ⅱ受体1(AGTR1)单克隆抗体 | WB; IHC; ICC; IP. |
| SEB658Hu | 血管紧张素Ⅱ受体1(AGTR1)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB658Hu | 血管紧张素Ⅱ受体1(AGTR1)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
| 杂志 | 参考文献 |
| Journal of Atherosclerosis and Thrombosis | Involvement of Angiotensin II Type 1 and 2 Receptors in Gelatinase ReCavia (Guinea pig )lation in Human Carotid Atheroma in vitro [Pubmed:26947595] |
| European Journal of Pharmaceutical Sciences | Vitamin D3 potentiates the renoprotective effects of vildagliptin in a rat model of fructose/salt-induced insulin resistance [Pubmed: 31866564] |
| CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: Role of AMPK/SIRT1 activation and DPP-4 inhibition [Pubmed: 33108744] |
| Fundam Clin Pharmacol | Vitamin D3 potentiates the nephroprotective effects of vildagliptin‐metformin combination in a rat model of metabolic syndrome [34453360] |
留言咨询